Often Neglected, Hope is on the Way for Fatty Liver Disease Patients

There is a June 22 PDUFA date for obeticholic acid, which if approved would become the first FDA-approved treatment for NASH.

Related Keywords

United States ,American ,Arun Jesudian ,Lorraine Stiehl ,A Sidney Barritt ,Division Of Gastroenterology ,American Liver Foundation Do ,Drug Development ,Presbyterian Hospital Weill Cornell Medical College ,Drug Administration ,American Liver Foundation ,Oliver Center ,Long Pursuit ,Weill Cornell Medical College ,Just One ,Sidney Barritt ,Associate Professor ,Oliver Think ,